Study to explore the effects of miglitol or sitagliptin on the incretin responses and respiratory metabolism function in type 2 diabetic patients with obesity
Latest Information Update: 06 Dec 2018
At a glance
- Drugs Miglitol (Primary) ; Sitagliptin (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 03 Dec 2018 Status changed from recruiting to discontinued.
- 02 Dec 2016 New trial record